Cardiopulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT) and Gene Therapy Workshop

The NIH is hosting a hybrid workshop that brings together experts to dive into new research regarding the future of HCT and gene therapy for sickle cell disease. This workshop provides an opportunity to contribute to improving care for patients with pulmonary complications.

Objectives:

1. Showcase the latest research breakthroughs funded under NOT-HL-20-761, focusing on pulmonary complications of HCT in childhood.
2. Foster collaboration to expand the scientific scope to include adults, devices, advanced analytics, and experimental human studies under NOT-HL-23-116.
3. Identify knowledge gaps to guide future research on pulmonary complications linked to HCT and gene therapy in sickle cell disease.

Visit the event page for more information.